Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Светлечок со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Prevalence of Autoantibodies in Patients of Type 1 Diabetes Mellitus   Omar Mohammed and Mohammed El-Khateeb

Prevalence of Autoantibodies in Patients of Type 1 Diabetes Mellitus

96 страниц. 2012 год.
LAP Lambert Academic Publishing
This study aimed to determine the prevalence of anti-glutamic acid decarboxylase autoantibodies (GADA) and anti-insulin autoantibodies (IAA) in patients with T1D and their siblings in Yemen. Thirty-one patients, thirty-six siblings and fourteen controls were tested for GADA and IAA. Anti-glutamic acid decarboxylase autoantibodies was present in 12 out of 31 patients (38.7%), in 1 out of 36 siblings (2.77%) and non of the controls (0.0%) while, IAA was positive in 20 out of 31 (64.5%), in 3 out of 36 (8.3%) and 0/14 (0.0%) in patients, siblings and controls, respectively. There was a significant difference in the prevalence of GADA in patients versus siblings and controls (P?0.001 and 0.007) respectively. There also was a significant difference in the prevalence of IAA in patients versus siblings and controls (P? 0.001 and ?0.001) respecively.
 
- Генерация страницы: 0.05 секунд -